Literature DB >> 15161568

High-dose intensity modulated radiation therapy for prostate cancer.

Deborah A Kuban1, Lei Dong.   

Abstract

The trend in prostate cancer radiation over the past several years has been to increase the dose to the gland while minimizing the dose to normal tissues. Intensity modulated radiation therapy is a computer-driven treatment planning and delivery system that has shown promise in improving disease-free outcome while decreasing the associated gastrointestinal and urinary complication rates. This technique continues to evolve, working toward image-guided radiation therapy, which is adjusted daily for positional and architectural changes of the gland.

Entities:  

Mesh：

Year:  2004        PMID： 15161568     DOI： 10.1007/s11934-004-0037-3

Source DB:  PubMed          Journal:  Curr Urol Rep        ISSN： 1527-2737            Impact factor:   2.862


  17 in total

1.  Importance of high radiation doses (72 Gy or greater) in the treatment of stage T1-T3 adenocarcinoma of the prostate.

Authors:  J A Lyons; P A Kupelian; D S Mohan; C A Reddy; E A Klein
Journal:  Urology       Date:  2000-01       Impact factor: 2.649

2.  Experience of ultrasound-based daily prostate localization.

Authors:  Anurag Chandra; Lei Dong; Eugene Huang; Deborah A Kuban; Laura O'Neill; Isaac Rosen; Alan Pollack
Journal:  Int J Radiat Oncol Biol Phys       Date:  2003-06-01       Impact factor: 7.038

3.  The effect of dose on local control of prostate cancer.

Authors:  G E Hanks; K L Martz; J J Diamond
Journal:  Int J Radiat Oncol Biol Phys       Date:  1988-12       Impact factor: 7.038

4.  High dose radiation delivered by intensity modulated conformal radiotherapy improves the outcome of localized prostate cancer.

Authors:  M J Zelefsky; Z Fuks; M Hunt; H J Lee; D Lombardi; C C Ling; V E Reuter; E S Venkatraman; S A Leibel
Journal:  J Urol       Date:  2001-09       Impact factor: 7.450

5.  Preliminary report of toxicity following 3D radiation therapy for prostate cancer on 3DOG/RTOG 9406.

Authors:  J M Michalski; J A Purdy; K Winter; M Roach; S Vijayakumar; H M Sandler; A M Markoe; M A Ritter; K J Russell; S Sailer; W B Harms; C A Perez; R B Wilder; G E Hanks; J D Cox
Journal:  Int J Radiat Oncol Biol Phys       Date:  2000-01-15       Impact factor: 7.038

6.  High-dose intensity modulated radiation therapy for prostate cancer: early toxicity and biochemical outcome in 772 patients.

Authors:  Michael J Zelefsky; Zvi Fuks; Margie Hunt; Yoshiya Yamada; Christine Marion; C Clifton Ling; Howard Amols; E S Venkatraman; Steven A Leibel
Journal:  Int J Radiat Oncol Biol Phys       Date:  2002-08-01       Impact factor: 7.038

7.  Dose response in prostate cancer with 8-12 years' follow-up.

Authors:  Gerald E Hanks; Alexandra L Hanlon; Barry Epstein; Eric M Horwitz
Journal:  Int J Radiat Oncol Biol Phys       Date:  2002-10-01       Impact factor: 7.038

8.  Characterization of rectal normal tissue complication probability after high-dose external beam radiotherapy for prostate cancer.

Authors:  Rex Cheung; Susan L Tucker; Jin-Song Ye; Lei Dong; Helen Liu; Eugene Huang; Radhe Mohan; Deborah Kuban
Journal:  Int J Radiat Oncol Biol Phys       Date:  2004-04-01       Impact factor: 7.038

9.  Long-term multi-institutional analysis of stage T1-T2 prostate cancer treated with radiotherapy in the PSA era.

Authors:  Deborah A Kuban; Howard D Thames; Larry B Levy; Eric M Horwitz; Patrick A Kupelian; Alvaro A Martinez; Jeff M Michalski; Thomas M Pisansky; Howard M Sandler; William U Shipley; Michael J Zelefsky; Anthony L Zietman
Journal:  Int J Radiat Oncol Biol Phys       Date:  2003-11-15       Impact factor: 7.038

10.  Preliminary evaluation of low-grade toxicity with conformal radiation therapy for prostate cancer on RTOG 9406 dose levels I and II.

Authors:  Jeff M Michalski; Kathryn Winter; James A Purdy; Richard B Wilder; Carlos A Perez; Mack Roach; Matthew B Parliament; Alan Pollack; Arnold M Markoe; W Harms; Howard M Sandler; James D Cox
Journal:  Int J Radiat Oncol Biol Phys       Date:  2003-05-01       Impact factor: 7.038
View more
  1 in total

1.  Colchicine sensitizes human hepatocellular carcinoma cells to damages caused by radiation.

Authors:  Chia-Yuan Liu; Hui-Fen Liao; Shou-Chuan Shih; Shee-Chan Lin; Wen-Hsiung Chang; Cheng-Hsin Chu; Tsang-En Wang; Yu-Jen Chen
Journal:  World J Gastroenterol       Date:  2005-07-21       Impact factor: 5.742
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.